Defective natural killer cell anti-viral capacity in paediatric HBV infection

Clinical and Experimental Immunology

Volumn 179, Issue 3, 2015, Pages 466-476

  Heiberg, I L ^a   Pallett, L J ^b   Winther, T N ^a   Hogh B ^a   Maini, M K ^b   Peppa, D ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti viral function; IFN ; NK cells; NKp30; Paediatric HBV infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPATITIS B(E) ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3 PROTEIN, HUMAN; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ADOLESCENT; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CELL INTERACTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ACTIVITY; FEMALE; HEPATITIS B; HUMAN; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS LOAD; CELL COMMUNICATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOTOXICITY; DOWN REGULATION; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; METABOLISM; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ANTIGENS, VIRAL; CELL COMMUNICATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3;

EID: 84922778651     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12470     Document Type: Article

References (57)

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373:582-592.
2. McMahon BJ, Alward WL, Hall DB etal. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151:599-603.
3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50:661-662.
4. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49:S45-55.
5. Shimakawa Y, Yan HJ, Tsuchiya N, Bottomley C, Hall AJ. Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. PLOS ONE 2013; 8:e69430.
6. Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 2011; 46:1-8.
7. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350:1118-1129.
8. Kennedy PT, Sandalova E, Jo J etal. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 2012; 143:637-645.
9. Chang MH. Paediatrics: children need optimal management of chronic hepatitis B. Nat Rev Gastroenterol Hepatol 2013; 10:505-506.
10. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-510.
11. Vivier E, Raulet DH, Moretta A etal. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-49.
12. Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Curr Opin Immunol 2013; 25:53-58.
13. Crome SQ, Lang PA, Lang KS, Ohashi PS. Natural killer cells regulate diverse T cell responses. Trends Immunol 2013; 34:342-349.
14. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012; 481:394-398.
15. Lang PA, Lang KS, Xu HC etal. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci USA 2012; 109:1210-1215.
16. Peppa D, Gill US, Reynolds G etal. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 2013; 210:99-114.
17. Oliviero B, Varchetta S, Paudice E etal. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009; 137:1151-1160. 60 e1-7.
18. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2011; 54:209-218.
19. Peppa D, Micco L, Javaid A etal. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLOS Pathog 2010; 6:e1001227.
20. Dunn C, Brunetto M, Reynolds G etal. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204:667-680.
21. Micco L, Peppa D, Loggi E etal. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. J Hepatol 2013; 58:225-233.
22. Dominguez E, Madrigal JA, Layrisse Z, Cohen SB. Fetal natural killer cell function is suppressed. Immunology 1998; 94:109-114.
23. Le Garff-Tavernier M, Beziat V, Decocq J etal. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010; 9:527-535.
24. Almeida-Oliveira A, Smith-Carvalho M, Porto LC etal. Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol 2011; 72:319-329.
25. Lee YC, Lin SJ. Neonatal natural killer cell function: relevance to antiviral immune defense. Clin Dev Immunol 2013; 2013:427696.
26. Dunn C, Peppa D, Khanna P etal. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009; 137:1289-1300.
27. Sundstrom Y, Nilsson C, Lilja G, Karre K, Troye-Blomberg M, Berg L. The expression of human natural killer cell receptors in early life. Scand J Immunol 2007; 66:335-344.
28. Almehmadi M, Flanagan BF, Khan N, Alomar S, Christmas SE. Increased numbers and functional activity of CD56(+) T cells in healthy cytomegalovirus positive subjects. Immunology 2014; 142:258-268.
29. Ferlazzo G, Morandi B, D'Agostino A etal. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003; 33:306-313.
30. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.
31. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192:921-930.
32. Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010; 115:2167-2176.
33. Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev 2005; 126:722-731.
34. Bonorino P, Ramzan M, Camous X etal. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 2009; 51:458-467.
35. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004; 104:3664-3671.
36. Monsivais-Urenda A, Noyola-Cherpitel D, Hernandez-Salinas A etal. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010; 40:1418-1427.
37. Beziat V, Dalgard O, Asselah T etal. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2012; 42:447-457.
38. Nielsen CM, White MJ, Goodier MR, Riley EM. Functional significance of CD57 expression on human NK cells and relevance to disease. Front Immunol 2013; 4:422.
39. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23:255-259.
40. Das A, Ellis G, Pallant C etal. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012; 189:3925-3935.
41. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006; 118:1-10.
42. Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 2013; 19:859-868.
43. Maini MK, Peppa D. NK cells: a double-edged sword in chronic hepatitis B virus infection. Front Immunol 2013; 4:57.
44. Ballan WM, Vu BA, Long BR etal. Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J Immunol 2007; 179:3362-3370.
45. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825-829.
46. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195:343-351.
47. Mavilio D, Lombardo G, Kinter A etal. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006; 203:2339-2350.
48. Shi CC, Tjwa ET, Biesta PJ etal. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells. J Viral Hepat 2012; 19:e26-33.
49. Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC, Janssen HL. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLOS ONE 2011; 6:e15324.
50. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2:957-964.
51. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: 'l'union fait la force'. Blood 2005; 106:2252-2258.
52. Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR. Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity. Hepatology 2012; 56:1214-1222.
53. Khakoo SI, Thio CL, Martin MP etal. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305:872-874.
54. Martin MP, Qi Y, Gao X etal. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39:733-740.
55. Ni YH, Chen DS. Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris) 2010; 58:296-300.
56. D'Antiga L, Aw M, Atkins M, Moorat A, Vergani D, Mieli-Vergani G. Combined lamivudine/interferon-alpha treatment in 'immunotolerant' children perinatally infected with hepatitis B: a pilot study. J Pediatr 2006; 148:228-233.
57. Carey I, D'Antiga L, Bansal S etal. Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy. J Virol 2011; 85:2416-2428.